knowledge -WSS

knowledge

author：hotspot 2025-08-25 07:28:13 - browse：578

Moderna chairman Noubar Afeyan exuded star power earlier this month as he commanded the spotlight at BIO 2023, the industry’s largest convention.

Basking in the accolades heaped on Moderna’s celebrated Covid-19 vaccine, Afeyan regaled the Boston audience with the company’s origin story and greeted fans who lined up to snap selfies with him. Stuart Cable, a partner in the law firm Goodwin who’s represented Moderna and joined Afeyan on stage, called Moderna “arguably the most successful story in the history of biotechnology.”

But the Cambridge, Mass.-based company can’t afford to rest on its laurels. Two and a half years after its vaccine liberated tens of millions from pandemic lockdowns — ringing up more than $36 billion in sales so far — Moderna faces a changing business and regulatory environment. Demand for Covid shots is waning, a backlash over drug prices is gaining traction, and questions about its next act loom.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Latest bird flu infection made farmworker sicker than earlier cases

WSS

Biden administration opens offers in Medicare drug price negotiations

Do more moles mean more problems? Not so, says new study

Biden administration opens offers in Medicare drug price negotiations

Medicare drug price negotiation’s day in court

Insmed lung disease drug hits target in key Phase 3 trial

Prosthetic arm enables patients to feel the objects they grip

Wikipedia

knowledge

entertainment

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Scientists successfully use ultrasound imaging to map brain activity

Drug repurposing or repositioning? The language matters

Childbirth

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

Sports medicine is finally prioritizing gender equality

General Catalyst, Summa Health deal will turn on physician buy

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Covid misinformation case heads to Supreme Court

hotspot

Do more moles mean more problems? Not so, says new study

Covid misinformation case heads to Supreme Court

What we need to know about Arena Bioworks

iTeos Therapeutics debuts first data on TIGIT

A $475,000 price tag for a new cancer drug: crazy or meh?

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

Wikipedia

entertainment

focus

entertainment